64 publications
| Name | Date | Type | Actions |
|---|---|---|---|
Buyback programs - November 2023 Monthly communication regarding buyback programs |
Description of buyback programs | ||
Buyback programs - december 2023 Monthly communication regarding buyback programs |
Description of buyback programs | ||
Buyback programs - october 2023 Monthly communication regarding buyback programs |
Description of buyback programs | ||
Sales 3rd quarter 2023: 136M€ The Vetoquinol Group posted sales of €136 million in Q3 2023, up +1.3% on a reported basis and +5.1% at constant exchange rates. Over the same period, Vetoquinol recorded a negative currency impact of -€5 million, linked to the Americas and Asia Pacific/Rest of World territories. |
Public releases | ||
Buyback programs - September 2023 (french) Monthly communication regarding buyback programs |
Description of buyback programs | ||
Monthly information regarding the total number of voting rights and shares making of the share capital - September 2023 As per articles L233-8-II of « Code de Commerce » and 223.16 of the «Reglement Général de L’Autorité des Marchés Financiers » |
Voting rights | ||
Sustainable development, an integral part of Vetoquinol Vetoquinol's corporate vision underlines its ambition for its entire ecosystem. This vision creates a dynamic for sustainable development by stating that by 2033 the company will be "the most agile animal health laboratory where employees, experts, partners, and customers work together to create customized solutions dedicated to animal health for a better planet". |
Press releases communication | ||
Rapport financier semestriel 2023 (french) Rapport financier semestriel 2023 (french) |
Half Year Report | ||
Monthly information regarding the total number of voting rights and shares making of the share capital - August 2023 As per articles L233-8-II of « Code de Commerce » and 223.16 of the «Reglement Général de L’Autorité des Marchés Financiers » |
Voting rights | ||
Buyback programs - August 2023 (french) Monthly communication regarding buyback programs |
Description of buyback programs | ||
2023 HALF-YEAR RESULTS Sales: €256m (-5.4% as reported) |
Public releases | ||
2023 Half-Year Results Contents |
Half Year Report | ||
Buyback programs - July Monthly communication regarding buyback programs |
Description of buyback programs | ||
Monthly information regarding the total number of voting rights - July 2023 As per articles L233‐8‐II of « Code de Commerce » and 223.16 of the «Reglement Général de L’Autorité des Marchés Financiers » |
Voting rights | ||
Mastaplex and Vetoquinol announce distribution agreement Mastaplex Ltd (New Zealand, unlisted) and Vetoquinol (VETO: France Euronext) are pleased to announce an extension of their exclusive distribution agreement for Mastatest.. |
Press releases communication | ||
Update July 11, 2023 2023 CALENDAR OF FINANCIAL COMMUNICATION Update July 11, 2023 |
Agenda | ||
Rapport financier semestriel 2022 (french) Rapport financier semestriel 2022 (french) |
Half Year Report | ||
Growth driven by innovation Ever since the company was founded in 1933, innovation has been a major component of Vetoquinol's development strategy. |
Press releases communication | ||
Rémunération et politique des dirigeants - mai 2023 (french) Rémunération et politique des dirigeants |
Shareholders´s Meeting | ||
Vetoquinol - assemblée générale mixte - 25 mai 2023 : résultat du scrutin |
Shareholders´s Meeting | ||
3rd generation appointed chairman of the board of directors of VETOQUINOL SA At the Combined General Meeting it was also announced that Mr. Etienne Frechin will resign as Chairman of the Board of Vetoquinol, effective 1st July 2023. Mr. Etienne Frechin will remain a Director of the company, hence continuing to share his broad experience. On 25 May 2023, the Board of Directors appointed Mr. Matthieu Frechin, Chief Executive Officer of the Group, as Chairman of the Board of Directors of Vetoquinol effective 1st July 2023. |
Press releases communication | ||
Assemblée générale - Vetoquinol SA 25 mai 2023 Ordre du jour : |
Shareholders´s Meeting | ||
Information mensuelle relative au nombre total de droits de vote et d’actions composant le capital social – record date Conformément aux dispositions des articles L233-8-II du Code de Commerce et 223-16 du Règlement Général de l’Autorité des Marchés Financiers |
Shareholders´s Meeting | ||
Universal registration document 2022 Universal Registration Document including the Annual Financial Report |
Reference document | ||
Essential products Essential products for the most common needs |
Press releases communication | ||
Worlds Top 10 The animal health company is firmly established in the world's Top 10. |
Press releases communication | ||
Q1 2023 Sales: €145M Vetoquinol recorded sales of €145 million for the first three months of the 2023 financial year, up 7.7% on a reported basis and 7.2% at constant exchange rates. |
Public releases | ||
BALO : Avis de convocation / avis de réunion Mesdames et Messieurs les actionnaires sont convoqués le jeudi 25 mai 2023 à 11h00 au siège social, Magny-Vernois 70200 LURE, en Assemblée générale mixte, à l’effet de délibérer sur l’ordre du jour et les projets de résolutions ci-après. |
Shareholders´s Meeting | ||
Document d’enregistrement universel (URD) 2022 version XBRL Document d'enregistrement universel 2022 incluant le rapport financier annuel |
Reference document | ||
Availability of the 2022 universal registration document On 13 April 2023, Vetoquinol filed its 2022 Universal Registration Document with the Autorité des Marchés Financiers (AMF) in ESEF (European Single Electronic Format). |
Public releases | ||
Monthly information regarding the total number of voting rights - April 2023 As per articles L233‐8‐II of « Code de Commerce » and 223.16 of the «Reglement Général de L’Autorité des Marchés Financiers» |
Voting rights | ||
Monthly information regarding the total number of voting rights - May 2023 As per articles L233‐8‐II of « Code de Commerce » and 223.16 of the «Reglement Général de L’Autorité des Marchés Financiers» |
Voting rights | ||
Monthly information regarding the total number of voting rights - June 2023 As per articles L233‐8‐II of « Code de Commerce » and 223.16 of the «Reglement Général de L’Autorité des Marchés Financiers» |
Voting rights | ||
Monthly information regarding the total number of voting rights - March 2023 As per articles L233‐8‐II of « Code de Commerce » and 223.16 of the «Reglement Général de L’Autorité des Marchés Financiers» |
Voting rights | ||
Clone of Buyback programs – April 2023 Monthly communication regarding buyback programs |
Monthly communication regarding buyback programs | ||
Buyback programs – May 2023 Monthly communication regarding buyback programs |
Monthly communication regarding buyback programs | ||
Buyback programs – June 2023 Monthly communication regarding buyback programs |
Monthly communication regarding buyback programs | ||
Buyback programs – March 2023 Monthly communication regarding buyback programs |
Monthly communication regarding buyback programs | ||
A visionary strategy The key steps of a visionary strategy |
Press releases communication | ||
[VIDEO] Présentation des résultats annuels 2022 -French Présentation analystes & investisseurs - 23 Mars 2023 |
Annual Report | ||
ANNUAL RESULTS 2022 (slideshow) 01.2022 Highlights |
Annual Report | ||
2022 ANNUAL RESULTS Annual sales: €540m (up 3.6% as reported) |
Public releases | ||
Serving animal Health - 90 years Serving animal Health for over 90 years |
Press releases communication | ||
Monthly information regarding the total number of voting rights - February 2023 As per articles L233‐8‐II of « Code de Commerce » and 223.16 of the « Reglement Général de L’Autorité des Marchés Financiers » |
Voting rights | ||
Buyback programs - February 2023 Monthly communication regarding buyback programs |
Description of buyback programs | ||
Monthly information regarding the total number of voting rights - January 2023 As per articles L233‐8‐II of « Code de Commerce » and 223.16 of the «Reglement Général de L’Autorité des Marchés Financiers » |
Voting rights | ||
Buyback programs - January 2023 Monthly communication regarding buyback programs |
Description of buyback programs | ||
In 2023 Vetoquinol celebrates its 90th anniversary. - 90 years The story of an incredible family saga. From a regional pharmaceutical laboratory to a world leader in animal health. |
Press releases communication | ||
Annual sales 2022 Total group Sales: €540 million (up 3.6% as reported) |
Public releases | ||
CALENDAR 2023 Stock exchange market – non authorized periods The "negative windows" are the abstention periods during which it is forbidden to trade in the Company's securities. |
Financial Documents | ||
2023 calendar of financial communication Vetoquinol published its calendar of financial communication for 2023. |
Agenda | ||
Monthly information regarding the total number of voting rights - december 2022 As per articles L233‐8‐II of « Code de Commerce » and 223.16 of the «Reglement Général de L’Autorité des Marchés Financiers » |
Voting rights | ||
Buyback programs - december 2022 Monthly communication regarding buyback programs |
Description of buyback programs | ||
Rapport complémentaire du conseil d'administration sur l'utilisation des délégations de compétence - conseil d'administration du 16 novembre 2006 (french) |
|||
Descriptif du programme de rachat par la société de ses propres actions autorisé par l'assemblée générale mixte des actionnaires du 9 octobre 2006 et mis en œuvre par le conseil d'administration du 8 décembre 2006 (french) |
Description of buyback programs | ||
Mise en place d'un contrat de liquidité (french) |
|||
Annonce de la fin de la période de stabilisation (french) |
Ipo | ||
Exercice intégral de l'option de sur-allocation (french) |
Ipo | ||
Vetoquinol Succes IPO (french) |
Ipo | ||
Visa AMF (french) |
Ipo | ||
Note d'opération n°06-388 (french) |
Ipo | ||
Initial public offering: Eurolist of Euronext Paris |
Ipo | ||
Enregistrement du document de base (french) |
Ipo | ||
Document de base n° I-06.165 (french) |
Ipo |